MID-VOLUME · FEMALE-LED
buspirone Side Effects
buspirone (also sold as BuSpar) sits MID-VOLUME #316 of 524 by FAERS report count. Lead signal: FEMALE-LED - 75% of sex-coded reports are female (7,174 F / 2,427 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 10,228
- FAERS reports
FDA Adverse Event Reporting System extract for buspirone. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.
buspirone reporting skew - 75% of sex-coded reports are female (7,174 F / 2,427 M). Volume band MID-VOLUME #316 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for buspirone (BuSpar) (10,228 reports). Signature FEMALE-LED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2003–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
FATIGUE leads 759 of 10,228 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (75% of sex-coded rows)
Age peak 45-64 (2,197 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (694 reports, 6.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| COMPLETED SUICIDE | 244 |
| DEATH | 211 |
| TOXICITY TO VARIOUS AGENTS | 83 |
| CARDIAC ARREST | 53 |
| CARDIO-RESPIRATORY ARREST | 46 |
| RESPIRATORY ARREST | 40 |
| DYSPNOEA | 33 |
| OVERDOSE | 33 |
| NAUSEA | 28 |
| DRUG ABUSE | 27 |
| POISONING | 25 |
| ANXIETY | 21 |
| FALL | 18 |
| DIARRHOEA | 16 |
| PNEUMONIA | 16 |
| RENAL FAILURE | 16 |
| ASTHENIA | 15 |
| DRUG INTERACTION | 15 |
| PULMONARY OEDEMA | 15 |
| FATIGUE | 14 |
Reactions in Hospitalization Reports
Hospitalization mid-share (2,354, 23.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 223 |
| NAUSEA | 209 |
| FALL | 204 |
| PNEUMONIA | 199 |
| FATIGUE | 191 |
| PAIN | 176 |
| HEADACHE | 172 |
| ANXIETY | 162 |
| DIZZINESS | 149 |
| HOSPITALISATION | 143 |
| DIARRHOEA | 139 |
| VOMITING | 136 |
| URINARY TRACT INFECTION | 131 |
| DEPRESSION | 115 |
| WEIGHT INCREASED | 100 |
| MALAISE | 99 |
| ASTHENIA | 98 |
| BACK PAIN | 95 |
How to read buspirone FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 10,228 voluntary reports linked to buspirone (BuSpar), 2003-2025. Death is listed on 694 (6.8%). Hospitalization appears on 2,354 (23.0%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 75% of sex-coded reports are female (7,174 F / 2,427 M).
Read with buspirone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 10,232 FAERS cases (Δ 4 heavier vs buspirone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 10,243 FAERS cases (Δ 15 heavier vs buspirone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 10,248 FAERS cases (Δ 20 heavier vs buspirone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 10,198 FAERS cases (Δ 30 lighter vs buspirone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.3 pp vs buspirone's DEATH-HEAVY): CASELOAD · HOSP-MID.
buspirone stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.